Article Versions Notes

Liontos M, Terpos E, Markellos C, Zagouri F, Briasoulis A, Katsiana I, Skafida E, Fiste O, Kunadis E, Andrikopoulou A, et al. Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors. Vaccines. 2021; 9(10):1148. https://doi.org/10.3390/vaccines9101148

Liontos, Michalis, Evangelos Terpos, Christos Markellos, Flora Zagouri, Alexandros Briasoulis, Ioanna Katsiana, Efthymia Skafida, Oraianthi Fiste, Elena Kunadis, Angeliki Andrikopoulou, and et al. 2021. "Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors" Vaccines 9, no. 10: 1148. https://doi.org/10.3390/vaccines9101148

Liontos, M., Terpos, E., Markellos, C., Zagouri, F., Briasoulis, A., Katsiana, I., Skafida, E., Fiste, O., Kunadis, E., Andrikopoulou, A., Kaparelou, M., Koutsoukos, K., Gavriatopoulou, M., Kastritis, E., Trougakos, I. P., & Dimopoulos, M.-A. (2021). Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors. Vaccines, 9(10), 1148. https://doi.org/10.3390/vaccines9101148